Skip to content
Axcess News – Lifestyle
Author:
Clene Inc.
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
August 14, 2026
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
August 12, 2026
Clene to Present at The Canaccord 46th Annual Growth Conference
July 29, 2026
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
May 14, 2026
Miami International Holdings Reports First Quarter 2026 Results
May 8, 2026
Clene Announces $7 Million Underwritten Offering of Common Stock
May 5, 2026
Clene to Present at Upcoming May Conferences
May 5, 2026
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
May 4, 2026
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
March 12, 2026
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts
March 5, 2026
1
2
Next Page
→